Cargando…
Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management
Acute hematogenous osteomyelitis (AHO) is a common invasive infection encountered in the pediatric population. In addition to the acute illness, AHO has the potential to create long-term morbidity and functional limitations. While a number of pathogens may cause AHO, Staphylococcus aureus is the mos...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751737/ https://www.ncbi.nlm.nih.gov/pubmed/33364793 http://dx.doi.org/10.2147/IDR.S257517 |
_version_ | 1783625717296136192 |
---|---|
author | McNeil, J Chase |
author_facet | McNeil, J Chase |
author_sort | McNeil, J Chase |
collection | PubMed |
description | Acute hematogenous osteomyelitis (AHO) is a common invasive infection encountered in the pediatric population. In addition to the acute illness, AHO has the potential to create long-term morbidity and functional limitations. While a number of pathogens may cause AHO, Staphylococcus aureus is the most common organism identified. Despite the frequency of this illness, little high-quality data exist to guide providers in the care of these patients. The literature is reviewed regarding the epidemiology, microbiology and management of AHO in children. A framework for empiric therapy is provided drawing from the available literature and published guidelines. |
format | Online Article Text |
id | pubmed-7751737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-77517372020-12-22 Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management McNeil, J Chase Infect Drug Resist Review Acute hematogenous osteomyelitis (AHO) is a common invasive infection encountered in the pediatric population. In addition to the acute illness, AHO has the potential to create long-term morbidity and functional limitations. While a number of pathogens may cause AHO, Staphylococcus aureus is the most common organism identified. Despite the frequency of this illness, little high-quality data exist to guide providers in the care of these patients. The literature is reviewed regarding the epidemiology, microbiology and management of AHO in children. A framework for empiric therapy is provided drawing from the available literature and published guidelines. Dove 2020-12-14 /pmc/articles/PMC7751737/ /pubmed/33364793 http://dx.doi.org/10.2147/IDR.S257517 Text en © 2020 McNeil. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review McNeil, J Chase Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management |
title | Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management |
title_full | Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management |
title_fullStr | Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management |
title_full_unstemmed | Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management |
title_short | Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management |
title_sort | acute hematogenous osteomyelitis in children: clinical presentation and management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751737/ https://www.ncbi.nlm.nih.gov/pubmed/33364793 http://dx.doi.org/10.2147/IDR.S257517 |
work_keys_str_mv | AT mcneiljchase acutehematogenousosteomyelitisinchildrenclinicalpresentationandmanagement |